A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug

被引：1
|
作者：
Abahussain, Abdulaziz A. M. [1 ]
Zaidi, S. Z. J. [2 ]
Nazir, M. H. [2 ,3 ]
Raza, M. [2 ]
Hassan, S. [4 ]
机构：
[1] King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia
[2] Univ Punjab, Inst Chem Engn & Technol, Lab Energy Water & Healthcare Technol, Lahore 54000, Punjab, Pakistan
[3] Univ South Wales, Fac Comp Engn & Sci, Caerleon, Wales
[4] Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China
来源：
JOURNAL OF NEW MATERIALS FOR ELECTROCHEMICAL SYSTEMS | 2022年 / 25卷 / 04期
关键词：
gemcitabine; graphene; density functional theory; drug delivery;
D O I：
10.14447/jnmes.v25i4.a02
中图分类号：
O646 [电化学、电解、磁化学];
学科分类号：
081704 ;
摘要：
Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.
引用
收藏
页码：234 / 239
页数：6
相关论文
共 50 条
  • [31] A DFT study of the degradation mechanism of anticancer drug carmustine in an aqueous medium
    Hadidi, Saba
    Shiri, Farshad
    Norouzibazaz, Mohammadsaleh
    STRUCTURAL CHEMISTRY, 2019, 30 (04) : 1315 - 1321
  • [32] Inclusion of capecitabine into cucurbiturils: DFT study for supramolecular encapsulation of anticancer drug
    Sin, Kye-Ryong
    Kim, Chol-Jin
    Ko, Sun-Gyong
    Pak, Sung-Hui
    Son, Mun-Ho
    Choe, Mun-Il
    MONATSHEFTE FUR CHEMIE, 2021, 152 (02): : 209 - 216
  • [33] A DFT study of the degradation mechanism of anticancer drug carmustine in an aqueous medium
    Saba Hadidi
    Farshad Shiri
    Mohammadsaleh Norouzibazaz
    Structural Chemistry, 2019, 30 : 1315 - 1321
  • [34] Inclusion of capecitabine into cucurbiturils: DFT study for supramolecular encapsulation of anticancer drug
    Kye-Ryong Sin
    Chol-Jin Kim
    Sun-Gyong Ko
    Sung-Hui Pak
    Mun-Ho Son
    Mun-Il Choe
    Monatshefte für Chemie - Chemical Monthly, 2021, 152 : 209 - 216
  • [35] Bioactive Polysaccharides Based Graphene Oxide Nanoparticle as a Promising Carrier for Anticancer Drug Delivery
    Kesavan, Sonia
    Meena, Karunakaran Sulochana
    Dhakshinamoorthy, Rajesh
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2022, 12 (03): : 3429 - 3445
  • [36] Direct noncovalent conjugation of folic acid on reduced graphene oxide as anticancer drug carrier
    Park, Young Ho
    Park, Sung Young
    In, Insik
    JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2015, 30 : 190 - 196
  • [37] Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine
    Pereira, S
    Fernandes, PA
    Ramos, MJ
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (10) : 1286 - 1294
  • [38] Drug carrier systems for anticancer agents: A review
    Chadha, Renu
    Kapoor, V. K.
    Thakur, Deepika
    Kaur, Rupinder
    Arora, Poonam
    Jain, D. V. S.
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2008, 67 (03): : 185 - 197
  • [39] Photoresponsive hyaluronate nanogel as an anticancer drug carrier
    Park, SoHyun
    Oh, Kyung Taek
    Kwag, Dong Sup
    Lee, Ung Yeol
    Lee, Dong Jin
    Lee, Eun Seong
    POLYMERS FOR ADVANCED TECHNOLOGIES, 2013, 24 (09) : 791 - 796
  • [40] Apomaghemite as a doxorubicin carrier for anticancer drug delivery
    Jurado, Rocio
    Fraczek, Paulina
    Droetto, Melissa
    Sanchez, Purificacion
    Valero, Elsa
    Dominguez-Vera, Jose M.
    Galvez, Natividad
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2016, 157 : 46 - 51
12345